Birchview Capital, LP Gossamer Bio, Inc. Transaction History
Birchview Capital, LP
- $95 Million
- Q2 2025
A detailed history of Birchview Capital, LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Birchview Capital, LP holds 138,176 shares of GOSS stock, worth $313,659. This represents 0.18% of its overall portfolio holdings.
Number of Shares
138,176
Previous 138,176
-0.0%
Holding current value
$313,659
Previous $151,000
11.92%
% of portfolio
0.18%
Previous 0.14%
Shares
11 transactions
Others Institutions Holding GOSS
# of Institutions
144Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$41.7 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$41.1 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$25.9 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$18.3 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$16.2 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $213M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...